Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found no reduction. To evaluate whether effects of screening on prostate cancer mortality relat...

Celý popis

Podrobná bibliografie

Vydáno v:	Annals of internal medicine Ročník 167; číslo 7; s. 449
Hlavní autoři:	Tsodikov, Alex, Gulati, Roman, Heijnsdijk, Eveline A M, Pinsky, Paul F, Moss, Sue M, Qiu, Sheng, de Carvalho, Tiago M, Hugosson, Jonas, Berg, Christine D, Auvinen, Anssi, Andriole, Gerald L, Roobol, Monique J, Crawford, E David, Nelen, Vera, Kwiatkowski, Maciej, Zappa, Marco, Luján, Marcos, Villers, Arnauld, Feuer, Eric J, de Koning, Harry J, Mariotto, Angela B, Etzioni, Ruth
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 03.10.2017
Témata:	Aged Early Detection of Cancer - statistics & numerical data Europe - epidemiology Humans Incidence Male Mass Screening - statistics & numerical data Middle Aged Proportional Hazards Models Prostatic Neoplasms - diagnosis Prostatic Neoplasms - epidemiology Prostatic Neoplasms - mortality Randomized Controlled Trials as Topic Time Factors United States - epidemiology
ISSN:	1539-3704, 1539-3704
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!